Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12-14

AUTHORS

Meryl Darlington, Bruno Carbonne, Agnès Mailloux, Yves Brossard, Annie Levy-Mozziconacci, Anne Cortey, Hassani Maoulida, Tabassome Simon, Alexandra Rousseau, Isabelle Durand-Zaleski

ABSTRACT

BackgroundThe determination of foetal Rhesus D (RHD) status allows appropriate use of IgRh prophylaxis by restricting its use to cases of RHD feto-maternal incompatibilities. There is a degree of uncertainty about the cost-effectiveness of foetal RHD determination, yet screening programs are being introduced into clinical practice in many countries.This paper evaluates the impact of non-invasive foetal Rhesus D (RHD) status determination on the costs of managing RHD-negative pregnant women and on the appropriate use of anti-D prophylaxis in a large sample of RHD-negative pregnant women using individual prospectively collected clinical and economic data.MethodsA prospective two-armed trial of RHD negative pregnant women was performed in 11 French Obstetric Departments. Non-invasive foetal RHD genotyping was performed before 26 weeks' gestation in the experimental arm whereas the control arm participants received usual care. The costs associated with patient management in relation to their RHD negative status (biological tests, anti-D prophylaxis and visits) were calculated from inclusion to the end of the postpartum period. The costs of hospital admissions during pregnancy and delivery were also determined.ResultsA total of 949 patients were included by 11 centres between 2009 and 2012, and 850 completed follow-up, including medical and biological monitoring. Patients were separated into two groups: the genotyping group (n=515) and the control group (n=335). The cost of the genotyping was estimated at 140 euros per test. The total mean cost per patient was estimated at €3,259 (SD ± 1,120) and €3,004 (SD ± 1,004) in the genotyping and control groups respectively. The cost of delivery represented three quarters of the total cost in both groups. The performance of managing appropriately RHD negative anti-D prophylaxis was 88% in the genotyping group, versus 65% in the control group. Using the costs related to RHD status (biological tests, anti-D immunoglobulin injections and visits) the incremental cost-effectiveness ratio (ICER) was calculated to be €578 for each percentage gain in women receiving appropriate management.ConclusionEarly knowledge of the RHD status of the foetus using non-invasive foetal RHD genotyping significantly improved the management of RHD negative pregnancies with a small increase in cost.Trial registrationClinical trials registry-NCT00832962–13 January 2009 - retrospectively registered. More... »

PAGES

496

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12884-018-2114-5

DOI

http://dx.doi.org/10.1186/s12884-018-2114-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110648735

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30547830


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fetus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genotyping Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunologic Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pregnancy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pregnancy Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prenatal Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prenatal Diagnosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rh Isoimmunization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rh-Hr Blood-Group System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rho(D) Immune Globulin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411394.a", 
          "name": [
            "AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Darlington", 
        "givenName": "Meryl", 
        "id": "sg:person.01212005056.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212005056.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.412370.3", 
          "name": [
            "AP-HP, H\u00f4pital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carbonne", 
        "givenName": "Bruno", 
        "id": "sg:person.01021656142.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021656142.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 fonctionnelle biologique du centre national de r\u00e9f\u00e9rence en h\u00e9mobiologie p\u00e9rinatale (CNRHP), H\u00f4pital Saint Antoine, (AP-HP), 184 rue du Faubourg Saint-Antoine, 75012, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.412370.3", 
          "name": [
            "Unit\u00e9 fonctionnelle biologique du centre national de r\u00e9f\u00e9rence en h\u00e9mobiologie p\u00e9rinatale (CNRHP), H\u00f4pital Saint Antoine, (AP-HP), 184 rue du Faubourg Saint-Antoine, 75012, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mailloux", 
        "givenName": "Agn\u00e8s", 
        "id": "sg:person.010125311567.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010125311567.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 fonctionnelle biologique du centre national de r\u00e9f\u00e9rence en h\u00e9mobiologie p\u00e9rinatale (CNRHP), H\u00f4pital Saint Antoine, (AP-HP), 184 rue du Faubourg Saint-Antoine, 75012, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.412370.3", 
          "name": [
            "Unit\u00e9 fonctionnelle biologique du centre national de r\u00e9f\u00e9rence en h\u00e9mobiologie p\u00e9rinatale (CNRHP), H\u00f4pital Saint Antoine, (AP-HP), 184 rue du Faubourg Saint-Antoine, 75012, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brossard", 
        "givenName": "Yves", 
        "id": "sg:person.0775126163.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775126163.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HM, H\u00f4pital Nord, Chemin des Bourrely, 13915, Marseille cedex 20, France", 
          "id": "http://www.grid.ac/institutes/grid.414244.3", 
          "name": [
            "AP-HM, H\u00f4pital Nord, Chemin des Bourrely, 13915, Marseille cedex 20, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levy-Mozziconacci", 
        "givenName": "Annie", 
        "id": "sg:person.011526533774.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011526533774.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 fonctionnelle clinique du centre national de r\u00e9f\u00e9rence en h\u00e9mobiologie p\u00e9rinatale (CNRHP), H\u00f4pital Trousseau, (AP-HP), 26 avenue du Dr Arnold-Netter, 75012, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413776.0", 
          "name": [
            "Unit\u00e9 fonctionnelle clinique du centre national de r\u00e9f\u00e9rence en h\u00e9mobiologie p\u00e9rinatale (CNRHP), H\u00f4pital Trousseau, (AP-HP), 26 avenue du Dr Arnold-Netter, 75012, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cortey", 
        "givenName": "Anne", 
        "id": "sg:person.01046112756.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046112756.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411394.a", 
          "name": [
            "AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maoulida", 
        "givenName": "Hassani", 
        "id": "sg:person.01206661465.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206661465.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, Unit\u00e9 de Recherche Clinique de l\u2019Est Parisien (URC-Est), H\u00f4pital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.412370.3", 
          "name": [
            "AP-HP, Unit\u00e9 de Recherche Clinique de l\u2019Est Parisien (URC-Est), H\u00f4pital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Simon", 
        "givenName": "Tabassome", 
        "id": "sg:person.01175655626.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175655626.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, Unit\u00e9 de Recherche Clinique de l\u2019Est Parisien (URC-Est), H\u00f4pital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.412370.3", 
          "name": [
            "AP-HP, Unit\u00e9 de Recherche Clinique de l\u2019Est Parisien (URC-Est), H\u00f4pital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rousseau", 
        "givenName": "Alexandra", 
        "id": "sg:person.0620475257.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620475257.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411394.a", 
          "name": [
            "AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Durand-Zaleski", 
        "givenName": "Isabelle", 
        "id": "sg:person.01327533357.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327533357.46"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00066982-200408010-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069123425", 
          "https://doi.org/10.2165/00066982-200408010-00004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03260044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029490774", 
          "https://doi.org/10.1007/bf03260044"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2393-14-87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045260414", 
          "https://doi.org/10.1186/1471-2393-14-87"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12-14", 
    "datePublishedReg": "2018-12-14", 
    "description": "BackgroundThe determination of foetal Rhesus D (RHD) status allows appropriate use of IgRh prophylaxis by restricting its use to cases of RHD feto-maternal incompatibilities. There is a degree of uncertainty about the cost-effectiveness of foetal RHD determination, yet screening programs are being introduced into clinical practice in many countries.This paper evaluates the impact of non-invasive foetal Rhesus D (RHD) status determination on the costs of managing RHD-negative pregnant women and on the appropriate use of anti-D prophylaxis in a large sample of RHD-negative pregnant women using individual prospectively collected clinical and economic data.MethodsA prospective two-armed trial of RHD negative pregnant women was performed in 11 French Obstetric Departments. Non-invasive foetal RHD genotyping was performed before 26 weeks' gestation in the experimental arm whereas the control arm participants received usual care. The costs associated with patient management in relation to their RHD negative status (biological tests, anti-D prophylaxis and visits) were calculated from inclusion to the end of the postpartum period. The costs of hospital admissions during pregnancy and delivery were also determined.ResultsA total of 949 patients were included by 11 centres between 2009 and 2012, and 850 completed follow-up, including medical and biological monitoring. Patients were separated into two groups: the genotyping group (n=515) and the control group (n=335). The cost of the genotyping was estimated at 140 euros per test. The total mean cost per patient was estimated at \u20ac3,259 (SD \u00b1 1,120) and \u20ac3,004 (SD \u00b1 1,004) in the genotyping and control groups respectively. The cost of delivery represented three quarters of the total cost in both groups. The performance of managing appropriately RHD negative anti-D prophylaxis was 88% in the genotyping group, versus 65% in the control group. Using the costs related to RHD status (biological tests, anti-D immunoglobulin injections and visits) the incremental cost-effectiveness ratio (ICER) was calculated to be \u20ac578 for each percentage gain in women receiving appropriate management.ConclusionEarly knowledge of the RHD status of the foetus using non-invasive foetal RHD genotyping significantly improved the management of RHD negative pregnancies with a small increase in cost.Trial registrationClinical trials registry-NCT00832962\u201313 January 2009 - retrospectively registered.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12884-018-2114-5", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024631", 
        "issn": [
          "1471-2393"
        ], 
        "name": "BMC Pregnancy and Childbirth", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "non-invasive foetal RHD", 
      "RhD-negative pregnant women", 
      "incremental cost-effectiveness ratio", 
      "pregnant women", 
      "control group", 
      "RhD status", 
      "feto-maternal incompatibility", 
      "RhD-negative status", 
      "RhD-negative pregnancies", 
      "control arm participants", 
      "total mean cost", 
      "negative pregnant women", 
      "two-arm study", 
      "cost-effectiveness ratio", 
      "appropriate use", 
      "foetal RHD", 
      "two-armed trial", 
      "Rhesus D status", 
      "D status", 
      "usual care", 
      "weeks' gestation", 
      "hospital admission", 
      "Obstetrics Department", 
      "arm participants", 
      "negative pregnancy", 
      "ResultsA total", 
      "experimental arm", 
      "postpartum period", 
      "negative mothers", 
      "patient management", 
      "negative status", 
      "mean cost", 
      "clinical practice", 
      "appropriate management", 
      "patients", 
      "women", 
      "pregnancy", 
      "gestation", 
      "RHD", 
      "biological monitoring", 
      "status", 
      "group", 
      "small increase", 
      "cost of delivery", 
      "genotyping", 
      "delivery", 
      "prophylaxis", 
      "admission", 
      "management", 
      "fetuses", 
      "large sample", 
      "status determination", 
      "trials", 
      "care", 
      "mothers", 
      "rhesus", 
      "total", 
      "total cost", 
      "Department", 
      "use", 
      "participants", 
      "arm", 
      "percentage gain", 
      "period", 
      "cases", 
      "economic data", 
      "center", 
      "study", 
      "increase", 
      "test", 
      "quarter", 
      "monitoring", 
      "program", 
      "practice", 
      "samples", 
      "data", 
      "inclusion", 
      "knowledge", 
      "effectiveness", 
      "ratio", 
      "impact", 
      "end", 
      "degree", 
      "countries", 
      "gain", 
      "cost", 
      "euro", 
      "determination", 
      "relation", 
      "incompatibility", 
      "degree of uncertainty", 
      "performance", 
      "uncertainty", 
      "paper"
    ], 
    "name": "Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women", 
    "pagination": "496", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110648735"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12884-018-2114-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30547830"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12884-018-2114-5", 
      "https://app.dimensions.ai/details/publication/pub.1110648735"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_782.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12884-018-2114-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12884-018-2114-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12884-018-2114-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12884-018-2114-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12884-018-2114-5'


 

This table displays all metadata directly associated to this object as RDF triples.

302 TRIPLES      21 PREDICATES      137 URIs      126 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12884-018-2114-5 schema:about N05b1cf04ff1a4a48a4a34abfa3f4d9cd
2 N112065adfb9740f8868c900f91ffea5d
3 N31aa6c78f81f4ea68d34a56c4c999e36
4 N343cdacbafef4c26aac74068a44d533e
5 N35286aae38cf49d69ee792dd96e32776
6 N4c549f23ff1846c690ac794a4a6b91de
7 N651cdc8773ea48a8b4f25624d4f432c2
8 N6899389996ea47b2a804976b86945244
9 N759f7d27c0a84041b0b8d6dbaa9f5a92
10 N77416da700a049f8b5972dba89340468
11 Nb210676bd798457bb4839d220df9aea5
12 Nda052815469a440b8edcdcc100a776e8
13 Ne8297f5ac446496ca7405089da1ab5c6
14 Nf7da5c7c7cba4b59baf50fc1526ac16c
15 Nfe1aaf976bd442efa1fd3cebb8e68f89
16 anzsrc-for:11
17 anzsrc-for:1117
18 schema:author N94fe3f61c0b84dacb9c3d7f289cd201f
19 schema:citation sg:pub.10.1007/bf03260044
20 sg:pub.10.1186/1471-2393-14-87
21 sg:pub.10.2165/00066982-200408010-00004
22 schema:datePublished 2018-12-14
23 schema:datePublishedReg 2018-12-14
24 schema:description BackgroundThe determination of foetal Rhesus D (RHD) status allows appropriate use of IgRh prophylaxis by restricting its use to cases of RHD feto-maternal incompatibilities. There is a degree of uncertainty about the cost-effectiveness of foetal RHD determination, yet screening programs are being introduced into clinical practice in many countries.This paper evaluates the impact of non-invasive foetal Rhesus D (RHD) status determination on the costs of managing RHD-negative pregnant women and on the appropriate use of anti-D prophylaxis in a large sample of RHD-negative pregnant women using individual prospectively collected clinical and economic data.MethodsA prospective two-armed trial of RHD negative pregnant women was performed in 11 French Obstetric Departments. Non-invasive foetal RHD genotyping was performed before 26 weeks' gestation in the experimental arm whereas the control arm participants received usual care. The costs associated with patient management in relation to their RHD negative status (biological tests, anti-D prophylaxis and visits) were calculated from inclusion to the end of the postpartum period. The costs of hospital admissions during pregnancy and delivery were also determined.ResultsA total of 949 patients were included by 11 centres between 2009 and 2012, and 850 completed follow-up, including medical and biological monitoring. Patients were separated into two groups: the genotyping group (n=515) and the control group (n=335). The cost of the genotyping was estimated at 140 euros per test. The total mean cost per patient was estimated at €3,259 (SD ± 1,120) and €3,004 (SD ± 1,004) in the genotyping and control groups respectively. The cost of delivery represented three quarters of the total cost in both groups. The performance of managing appropriately RHD negative anti-D prophylaxis was 88% in the genotyping group, versus 65% in the control group. Using the costs related to RHD status (biological tests, anti-D immunoglobulin injections and visits) the incremental cost-effectiveness ratio (ICER) was calculated to be €578 for each percentage gain in women receiving appropriate management.ConclusionEarly knowledge of the RHD status of the foetus using non-invasive foetal RHD genotyping significantly improved the management of RHD negative pregnancies with a small increase in cost.Trial registrationClinical trials registry-NCT00832962–13 January 2009 - retrospectively registered.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf Nf259a70dbe28460989658e94f8c8e68f
28 Nfe901cdae3f141be9904645f7a962df1
29 sg:journal.1024631
30 schema:keywords D status
31 Department
32 Obstetrics Department
33 RHD
34 ResultsA total
35 RhD status
36 RhD-negative pregnancies
37 RhD-negative pregnant women
38 RhD-negative status
39 Rhesus D status
40 admission
41 appropriate management
42 appropriate use
43 arm
44 arm participants
45 biological monitoring
46 care
47 cases
48 center
49 clinical practice
50 control arm participants
51 control group
52 cost
53 cost of delivery
54 cost-effectiveness ratio
55 countries
56 data
57 degree
58 degree of uncertainty
59 delivery
60 determination
61 economic data
62 effectiveness
63 end
64 euro
65 experimental arm
66 feto-maternal incompatibility
67 fetuses
68 foetal RHD
69 gain
70 genotyping
71 gestation
72 group
73 hospital admission
74 impact
75 inclusion
76 incompatibility
77 increase
78 incremental cost-effectiveness ratio
79 knowledge
80 large sample
81 management
82 mean cost
83 monitoring
84 mothers
85 negative mothers
86 negative pregnancy
87 negative pregnant women
88 negative status
89 non-invasive foetal RHD
90 paper
91 participants
92 patient management
93 patients
94 percentage gain
95 performance
96 period
97 postpartum period
98 practice
99 pregnancy
100 pregnant women
101 program
102 prophylaxis
103 quarter
104 ratio
105 relation
106 rhesus
107 samples
108 small increase
109 status
110 status determination
111 study
112 test
113 total
114 total cost
115 total mean cost
116 trials
117 two-arm study
118 two-armed trial
119 uncertainty
120 use
121 usual care
122 weeks' gestation
123 women
124 schema:name Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women
125 schema:pagination 496
126 schema:productId N3e4ac512dd1c4c15a6d9bfcfa5e133fe
127 N9b0f724176b04d72b7ffa82051f036b9
128 Ne44ffe88891e4ca39663584d123c2a7d
129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110648735
130 https://doi.org/10.1186/s12884-018-2114-5
131 schema:sdDatePublished 2022-12-01T06:37
132 schema:sdLicense https://scigraph.springernature.com/explorer/license/
133 schema:sdPublisher Nefc25d33bb8a49d9a0341abd5a20dd1a
134 schema:url https://doi.org/10.1186/s12884-018-2114-5
135 sgo:license sg:explorer/license/
136 sgo:sdDataset articles
137 rdf:type schema:ScholarlyArticle
138 N01434b5d58ba47df820edfda52446ac2 rdf:first sg:person.0775126163.39
139 rdf:rest Nd791bd2b37b04ffa99393e92e4f2d3cd
140 N05b1cf04ff1a4a48a4a34abfa3f4d9cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Female
142 rdf:type schema:DefinedTerm
143 N112065adfb9740f8868c900f91ffea5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Genotype
145 rdf:type schema:DefinedTerm
146 N31aa6c78f81f4ea68d34a56c4c999e36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Pregnancy Outcome
148 rdf:type schema:DefinedTerm
149 N343cdacbafef4c26aac74068a44d533e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Immunologic Factors
151 rdf:type schema:DefinedTerm
152 N35286aae38cf49d69ee792dd96e32776 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Prenatal Care
154 rdf:type schema:DefinedTerm
155 N39da04eae6434e1c9010bbfebd8d5804 rdf:first sg:person.01327533357.46
156 rdf:rest rdf:nil
157 N3e4ac512dd1c4c15a6d9bfcfa5e133fe schema:name pubmed_id
158 schema:value 30547830
159 rdf:type schema:PropertyValue
160 N4c549f23ff1846c690ac794a4a6b91de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Cost-Benefit Analysis
162 rdf:type schema:DefinedTerm
163 N4d5f03d4ab114d618622fc56aecfd8c3 rdf:first sg:person.01206661465.96
164 rdf:rest Nad0ecaaf4d69453cafed38982ae55a2d
165 N564ea7188e7147a79e6c9eca79a495f3 rdf:first sg:person.01046112756.31
166 rdf:rest N4d5f03d4ab114d618622fc56aecfd8c3
167 N651cdc8773ea48a8b4f25624d4f432c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Rh Isoimmunization
169 rdf:type schema:DefinedTerm
170 N6899389996ea47b2a804976b86945244 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Rho(D) Immune Globulin
172 rdf:type schema:DefinedTerm
173 N739b3a6ae74b48ceacaf09ed7ab185ce rdf:first sg:person.010125311567.17
174 rdf:rest N01434b5d58ba47df820edfda52446ac2
175 N759f7d27c0a84041b0b8d6dbaa9f5a92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name France
177 rdf:type schema:DefinedTerm
178 N77416da700a049f8b5972dba89340468 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Rh-Hr Blood-Group System
180 rdf:type schema:DefinedTerm
181 N7a4fb56cce7443edafed131bd93a0f7b rdf:first sg:person.01021656142.16
182 rdf:rest N739b3a6ae74b48ceacaf09ed7ab185ce
183 N94fe3f61c0b84dacb9c3d7f289cd201f rdf:first sg:person.01212005056.21
184 rdf:rest N7a4fb56cce7443edafed131bd93a0f7b
185 N9b0f724176b04d72b7ffa82051f036b9 schema:name doi
186 schema:value 10.1186/s12884-018-2114-5
187 rdf:type schema:PropertyValue
188 Nad0ecaaf4d69453cafed38982ae55a2d rdf:first sg:person.01175655626.43
189 rdf:rest Nc6e03a3052f04b0e84fc2850fe34faad
190 Nb210676bd798457bb4839d220df9aea5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Pregnancy
192 rdf:type schema:DefinedTerm
193 Nc6e03a3052f04b0e84fc2850fe34faad rdf:first sg:person.0620475257.71
194 rdf:rest N39da04eae6434e1c9010bbfebd8d5804
195 Nd791bd2b37b04ffa99393e92e4f2d3cd rdf:first sg:person.011526533774.25
196 rdf:rest N564ea7188e7147a79e6c9eca79a495f3
197 Nda052815469a440b8edcdcc100a776e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Prenatal Diagnosis
199 rdf:type schema:DefinedTerm
200 Ne44ffe88891e4ca39663584d123c2a7d schema:name dimensions_id
201 schema:value pub.1110648735
202 rdf:type schema:PropertyValue
203 Ne8297f5ac446496ca7405089da1ab5c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Genotyping Techniques
205 rdf:type schema:DefinedTerm
206 Nefc25d33bb8a49d9a0341abd5a20dd1a schema:name Springer Nature - SN SciGraph project
207 rdf:type schema:Organization
208 Nf259a70dbe28460989658e94f8c8e68f schema:volumeNumber 18
209 rdf:type schema:PublicationVolume
210 Nf7da5c7c7cba4b59baf50fc1526ac16c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Fetus
212 rdf:type schema:DefinedTerm
213 Nfe1aaf976bd442efa1fd3cebb8e68f89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Humans
215 rdf:type schema:DefinedTerm
216 Nfe901cdae3f141be9904645f7a962df1 schema:issueNumber 1
217 rdf:type schema:PublicationIssue
218 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
219 schema:name Medical and Health Sciences
220 rdf:type schema:DefinedTerm
221 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
222 schema:name Public Health and Health Services
223 rdf:type schema:DefinedTerm
224 sg:journal.1024631 schema:issn 1471-2393
225 schema:name BMC Pregnancy and Childbirth
226 schema:publisher Springer Nature
227 rdf:type schema:Periodical
228 sg:person.010125311567.17 schema:affiliation grid-institutes:grid.412370.3
229 schema:familyName Mailloux
230 schema:givenName Agnès
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010125311567.17
232 rdf:type schema:Person
233 sg:person.01021656142.16 schema:affiliation grid-institutes:grid.412370.3
234 schema:familyName Carbonne
235 schema:givenName Bruno
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021656142.16
237 rdf:type schema:Person
238 sg:person.01046112756.31 schema:affiliation grid-institutes:grid.413776.0
239 schema:familyName Cortey
240 schema:givenName Anne
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046112756.31
242 rdf:type schema:Person
243 sg:person.011526533774.25 schema:affiliation grid-institutes:grid.414244.3
244 schema:familyName Levy-Mozziconacci
245 schema:givenName Annie
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011526533774.25
247 rdf:type schema:Person
248 sg:person.01175655626.43 schema:affiliation grid-institutes:grid.412370.3
249 schema:familyName Simon
250 schema:givenName Tabassome
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175655626.43
252 rdf:type schema:Person
253 sg:person.01206661465.96 schema:affiliation grid-institutes:grid.411394.a
254 schema:familyName Maoulida
255 schema:givenName Hassani
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206661465.96
257 rdf:type schema:Person
258 sg:person.01212005056.21 schema:affiliation grid-institutes:grid.411394.a
259 schema:familyName Darlington
260 schema:givenName Meryl
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212005056.21
262 rdf:type schema:Person
263 sg:person.01327533357.46 schema:affiliation grid-institutes:grid.411394.a
264 schema:familyName Durand-Zaleski
265 schema:givenName Isabelle
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327533357.46
267 rdf:type schema:Person
268 sg:person.0620475257.71 schema:affiliation grid-institutes:grid.412370.3
269 schema:familyName Rousseau
270 schema:givenName Alexandra
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620475257.71
272 rdf:type schema:Person
273 sg:person.0775126163.39 schema:affiliation grid-institutes:grid.412370.3
274 schema:familyName Brossard
275 schema:givenName Yves
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775126163.39
277 rdf:type schema:Person
278 sg:pub.10.1007/bf03260044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029490774
279 https://doi.org/10.1007/bf03260044
280 rdf:type schema:CreativeWork
281 sg:pub.10.1186/1471-2393-14-87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045260414
282 https://doi.org/10.1186/1471-2393-14-87
283 rdf:type schema:CreativeWork
284 sg:pub.10.2165/00066982-200408010-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069123425
285 https://doi.org/10.2165/00066982-200408010-00004
286 rdf:type schema:CreativeWork
287 grid-institutes:grid.411394.a schema:alternateName AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France
288 schema:name AP-HP Health Economics Clinical Research Platform (URCEco), Hotel Dieu, Place de Parvis, 75004, Paris, France
289 rdf:type schema:Organization
290 grid-institutes:grid.412370.3 schema:alternateName AP-HP, Hôpital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France
291 AP-HP, Unité de Recherche Clinique de l’Est Parisien (URC-Est), Hôpital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France
292 Unité fonctionnelle biologique du centre national de référence en hémobiologie périnatale (CNRHP), Hôpital Saint Antoine, (AP-HP), 184 rue du Faubourg Saint-Antoine, 75012, Paris, France
293 schema:name AP-HP, Hôpital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France
294 AP-HP, Unité de Recherche Clinique de l’Est Parisien (URC-Est), Hôpital Saint Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France
295 Unité fonctionnelle biologique du centre national de référence en hémobiologie périnatale (CNRHP), Hôpital Saint Antoine, (AP-HP), 184 rue du Faubourg Saint-Antoine, 75012, Paris, France
296 rdf:type schema:Organization
297 grid-institutes:grid.413776.0 schema:alternateName Unité fonctionnelle clinique du centre national de référence en hémobiologie périnatale (CNRHP), Hôpital Trousseau, (AP-HP), 26 avenue du Dr Arnold-Netter, 75012, Paris, France
298 schema:name Unité fonctionnelle clinique du centre national de référence en hémobiologie périnatale (CNRHP), Hôpital Trousseau, (AP-HP), 26 avenue du Dr Arnold-Netter, 75012, Paris, France
299 rdf:type schema:Organization
300 grid-institutes:grid.414244.3 schema:alternateName AP-HM, Hôpital Nord, Chemin des Bourrely, 13915, Marseille cedex 20, France
301 schema:name AP-HM, Hôpital Nord, Chemin des Bourrely, 13915, Marseille cedex 20, France
302 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...